Osteoporosis guidelines
- PMID: 12821610
- PMCID: PMC161603
Osteoporosis guidelines
Comment on
-
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.CMAJ. 2002 Nov 12;167(10 Suppl):S1-34. CMAJ. 2002. PMID: 12427685 Free PMC article. Review.
Similar articles
-
Osteoporosis guidelines.CMAJ. 2003 Jun 24;168(13):1644; author reply 1645-6. CMAJ. 2003. PMID: 12821611 Free PMC article. No abstract available.
-
Commentary on Mobley and Others: importance of assumptions about VTE mortality in modeling the cost-effectiveness of osteoporosis therapies.Med Decis Making. 2006 Nov-Dec;26(6):633-5; author reply 636-7. doi: 10.1177/0272989X06295363. Med Decis Making. 2006. PMID: 17099202 No abstract available.
-
Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?Best Pract Res Clin Rheumatol. 2005 Dec;19(6):975-81. doi: 10.1016/j.berh.2005.06.007. Best Pract Res Clin Rheumatol. 2005. PMID: 16301191 Review.
-
[From effective to economical. The value of good osteoporosis therapy].MMW Fortschr Med. 2002 May 23;144(21):30-3. MMW Fortschr Med. 2002. PMID: 12134421 German. No abstract available.
-
Raloxifene for prevention of osteoporotic fractures.Am Fam Physician. 2005 Jul 1;72(1):132-4. Am Fam Physician. 2005. PMID: 16035693 Review. No abstract available.
Cited by
-
The 2003 Canadian recommendations for dyslipidemia management: revisions are needed.CMAJ. 2005 Apr 12;172(8):1027-31. doi: 10.1503/cmaj.1040202. CMAJ. 2005. PMID: 15824409 Free PMC article. No abstract available.
References
-
- Criteria for review and selection for abstracting. In: ACP Journal Club [Web site]. Available: www.acpjc.org/shared/purpose_and_procedure.htm (accessed 2003 May 26).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources